4 Healthcare Stock Stories for Weekend Investor Wellness

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Eli Lilly and Company (NYSE:LLY): Current price $30.70

Lilly and Kowa Pharmaceuticals America have announced the results of a study evaluating the efficacy of Livalo (pitavastatin) 4 mg compared with pravastatin 40 mg in lowering low-density lipoprotein cholesterol in HIV-infected adults with high cholesterol, or dyslipidemia. The evaluation was created as a superiority trial for the primary endpoint, percent reduction in LDL-C, and evaluated HIV-infected adults with dyslipidemia,with and without viral Hepatitis B or C. The study achieved its primary endpoint.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

LLY

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business